Medical Nutrition Market Size is valued at USD 13.1 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031.
The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the increasing prevalence of chronic diseases like cancer and diabetes, are primary drivers propelling market growth. Oral clinical nutrition, comprising vitamins, proteins, and carbohydrates in various forms such as powder, liquid, and semi-solid, is witnessing significant demand for oral consumption. Leading market players in the manufacturing of oral clinical nutrition products are innovating with new flavors to improve taste, thereby expanding their customer base and boosting product sales. This, in turn, drives market demand. The increasing incidence of cancer cases has heightened the need for nutritious food, driven by the adverse effects of cancer treatment, including appetite loss and malnutrition issues among adults, such as depletion of essential body nutrition proteins and vitamins.
The Medical Nutrition market is segmented on the basis of nutrition, patient type, indication, end-user and route of administration. Nutrition type segment includes proteins, carbohydrates, multi-vitamins and antioxidants, amino acids, fibers, minerals, and other. By patient type, the market is segmented as infants, adults, and geriatric populations. By indication, the market is segmented as diabetes, cancer, gastrointestinal diseases, metabolic syndromes, and other medical disorders. By end user, the market is segmented as hospitals, home care settings, long-term care facilities, and ambulatory surgical centers. By route of administration, categorized between oral, enteral, and parenteral delivery methods.
In the medical nutrition market, the Cancer segment is anticipated to hold a dominant position based on indication. This is mainly due to the substantial prevalence of cancer globally, with it being the second leading cause of death worldwide. Cancer patients often experience various nutritional challenges, including weight loss, malnutrition, and difficulty in eating, which can negatively impact their overall health and treatment outcomes. Consequently, there is an increasing acceptance of the significance of specialized nutritional support for cancer patients in order to facilitate the efficacy of cancer treatments, manage symptoms, enhance the quality of life, and address their unique dietary requirements, including chemotherapy and radiation therapy. Consequently, the Cancer segment is anticipated to hold a notable share of the medical nutrition market as healthcare providers continue emphasising nutritional interventions as a crucial aspect of comprehensive cancer care.
In the medical nutrition market, the Geriatric Nutrition segment is poised to maintain a leading position primarily due to the significant increase in the global geriatric population. As demographics shift towards an aging population worldwide, there's a corresponding rise in the prevalence of age-related health conditions and nutritional challenges among the elderly.Geriatric individuals often face unique dietary needs and challenges due to factors such as decreased appetite, changes in metabolism, and a higher risk of chronic diseases. Consequently, there's an increased demand for specialized nutritional products and services tailored to address these specific needs and support optimal health outcomes among older adults.
The growing population of individuals affected by non-communicable diseases like diabetes, hypertension, cancer, and chronic kidney diseases (CKDs) is anticipated to drive demand for oral clinical nutritional products in this area. Additionally, the increasing efforts among pharmaceutical and food & nutrition companies to broaden their product portfolios fuel this segment's growth. The Asia Pacific region is expected to experience rapid growth during the forecast period. This can be attributed to the development of healthcare infrastructure, improved healthcare reimbursement policies, government initiatives in the healthcare sector, and favourable economic growth, all of which contribute positively to market expansion. Furthermore, the presence of prominent players in this region is a significant factor driving regional growth.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 13.1 Bn |
| Revenue Forecast In 2031 | USD 20.2 Bn |
| Growth Rate CAGR | CAGR of 5.7% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Nutrition, Patient Type, Indication, End-User And Route Of Administration |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc; Baxter International Inc.; Otsuka Holdings Co.; Ltd.; Mead Johnson & Company; LLC; Danone Nutricia; Victus; Inc. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Patient Type:
By Indication:
By Route of Administration:
By End User:
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.